# OnCo record imunon (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/imunon/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "imunon" ;
  schema:name "Imunon"@en ;
  schema:alternateName "IMUNON, Inc."@en, "Celsion Corporation"@en, "Celsion"@en ;
  schema:description "Imunon, formerly Celsion, is a New Jersey company developing a DNA-based interleukin-12 immunotherapy for ovarian cancer after its heat-activated liposomal doxorubicin, ThermoDox, failed in liver cancer."@en ;
  schema:url <https://onco.cc/companies/imunon/>, <https://www.imunon.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.imunon.com>, <https://clinicaltrials.gov/search?lead=Imunon>, <https://en.wikipedia.org/wiki/Celsion_Corporation> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/hcc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:trials <https://onco.cc/trials/nct06915025/>, <https://onco.cc/trials/nct05739981/>, <https://onco.cc/trials/nct03393884/> .
